Login / Signup

Exploration of therapeutic role of montelukast and dexamethasone combination against paraquat induced inhalational toxicity.

Santa MandalNavneet VermaNilutpal Sharma BoraPiyali DeyJohirul IslamSanjai Kumar DwivediPronobesh Chattopadhyay
Published in: Inhalation toxicology (2020)
Given the advantage of therapeutic synergism activity of MON and DXM, it may be used in the prophylaxis of PQ-intoxication following clinical trials.
Keyphrases
  • clinical trial
  • high glucose
  • diabetic rats
  • low dose
  • high dose
  • randomized controlled trial
  • drug induced
  • endothelial cells
  • study protocol
  • phase iii
  • oxide nanoparticles